These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2702429)

  • 21. The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogen in the management of metastatic prostatic cancer.
    Lin BJ; Chen KK; Chen MT; Chang LS
    Urology; 1994 Jun; 43(6):834-7. PubMed ID: 8197647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the salivary testosterone level in aged].
    Jinrui H; Itoh N; Nitta T; Kurohata T; Tsukamoto T; Kumamoto Y; Umehara T
    Hinyokika Kiyo; 1994 Sep; 40(9):807-11. PubMed ID: 7801841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.
    Kaisary AV; Tyrrell CJ; Peeling WB; Griffiths K
    Br J Urol; 1991 May; 67(5):502-8. PubMed ID: 1828183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer.
    Røhl HF; Beuke HP
    Scand J Urol Nephrol; 1992; 26(1):11-4. PubMed ID: 1631501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment hormone levels in prostatic cancer.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct radioimmunoassay (RIA) of salivary testosterone: correlation with free and total serum testosterone.
    Vittek J; L'Hommedieu DG; Gordon GG; Rappaport SC; Southren AL
    Life Sci; 1985 Aug; 37(8):711-6. PubMed ID: 4021735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary and plasma bound and "free" testosterone in men and women.
    Khan-Dawood FS; Choe JK; Dawood MY
    Am J Obstet Gynecol; 1984 Feb; 148(4):441-5. PubMed ID: 6538069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence for the usefulness of the salivary testosterone radioimmunoassay in the assessment of androgenicity in man in basal and stimulated conditions.
    Magrini G; Chiodoni G; Rey F; Felber JP
    Horm Res; 1986; 23(2):65-73. PubMed ID: 3943772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy.
    Klugo RC; Farah RN; Cerny JC
    Urology; 1981 Jan; 17(1):49-50. PubMed ID: 7456197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to orchiectomy following Zoladex therapy for metastatic prostate carcinoma.
    Silver RI; Straus FH; Vogelzang NJ; Kellman H; Chodak GW
    Urology; 1991 Jan; 37(1):17-21. PubMed ID: 1702566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial.
    Østergren PB; Kistorp C; Fode M; Henderson J; Bennedbæk FN; Faber J; Sønksen J
    J Urol; 2017 Jun; 197(6):1441-1447. PubMed ID: 27939836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Testosterone serum concentrations after subcapsular orchiectomy (author's transl)].
    Senge T; Hülshoff T; Tunn U; Schenck B; Neumann F
    Urologe A; 1978 Nov; 17(6):382-4. PubMed ID: 726161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary testosterone levels in infertile men.
    Galard R; Antolín M; Catalán R; Magaña P; Schwartz S; Castellanos JM
    Int J Androl; 1987 Aug; 10(4):597-601. PubMed ID: 3654013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status.
    Goncharov N; Katsya G; Dobracheva A; Nizhnik A; Kolesnikova G; Herbst V; Westermann J
    Aging Male; 2006 Jun; 9(2):111-22. PubMed ID: 16916746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of saliva collection, handling and storage on salivary testosterone measurement.
    Durdiaková J; Fábryová H; Koborová I; Ostatníková D; Celec P
    Steroids; 2013 Dec; 78(14):1325-31. PubMed ID: 24051109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of testosterone deprivation in stage D1 carcinoma of the prostate.
    Kramolowsky EV
    J Urol; 1988 Jun; 139(6):1242-4. PubMed ID: 3373595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age related variation of salivary testosterone values in healthy Japanese males.
    Uchida A; Bribiescas RG; Ellison PT; Kanamori M; Ando J; Hirose N; Ono Y
    Aging Male; 2006 Dec; 9(4):207-13. PubMed ID: 17178556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary testosterone: a good measure to reflect free testosterone.
    Navarro MA; Gomez JM; Villabona CM; Bonnin R
    Arch Intern Med; 1987 Jun; 147(6):1189. PubMed ID: 3592888
    [No Abstract]   [Full Text] [Related]  

  • 39. Testosterone and gonadotrophin profiles in patients on daily or monthly LHRH analogue ICI 118630 (Zoladex) compared with orchiectomy.
    Grant JB; Ahmed SR; Shalet SM; Costello CB; Howell A; Blacklock NJ
    Br J Urol; 1986 Oct; 58(5):539-44. PubMed ID: 2946356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary oxalate excretion during anti-androgenic therapy.
    Tiselius HG; Varenhorst E; Carlström K; Larsson L
    Invest Urol; 1980 Sep; 18(2):110-1. PubMed ID: 6447675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.